SWTX logo

SpringWorks Therapeutics (SWTX) CAPEX

annual CAPEX:

$20.70M+$13.32M(+180.31%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SWTX annual capital expenditures is $20.70 million, with the most recent change of +$13.32 million (+180.31%) on December 31, 2024.
  • During the last 3 years, SWTX annual CAPEX has risen by +$18.68 million (+926.84%).
  • SWTX annual CAPEX is now at all-time high.

Performance

1-year change

+180.31%

3-year change

+926.84%

5-year change

-

15-year change

-

SWTX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

72.84%
SWTX annual capital expenditures is higher than 72.84% of companies in Healthcare sector

Range

All-time high

$20.70M
SWTX annual capital expenditures is currently at an all-time high

3-year low

$2.02M
SWTX annual capital expenditures is currently +926.84% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
SWTX previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
SWTX next annual earnings announcement has not yet been scheduled

OtherSWTXcash flow metrics

annual FCF

-$196.30M
SWTX annual free cash flow is -$196.30 million

annual CFO

-$175.60M
SWTX annual cash flow from operations is -$175.60 million

annual CFI

$64.55M
SWTX annual cash flow from investing activities is $64.55 million

annual CFF

$4.76M
SWTX annual cash flow from financing activities is $4.76 million

quarterly CAPEX:

$30.00K-$6.02M(-99.50%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX quarterly capital expenditures is $30.00 thousand, with the most recent change of -$6.02 million (-99.50%) on March 31, 2025.
  • Over the past year, SWTX quarterly CAPEX has dropped by -$547.00 thousand (-94.80%).
  • SWTX quarterly CAPEX is now -99.75% below its all-time high of $12.22 million, reached on June 30, 2024.

Performance

3-month change

-99.5%

1-year change

-94.8%

3-year change

-98.74%

5-year change

-

SWTX quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

13.91%
SWTX quarterly capital expenditures is higher than 13.91% of companies in Healthcare sector

Range

All-time high

$12.22M
SWTX quarterly capital expenditures is currently -99.75% below its historical high of $12.22 million

3-year low

-$2.30M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SWTX previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 7, 2025
SWTX next earnings announcement is scheduled for Aug 7, 2025

OtherSWTXcash flow metrics

quarterly FCF

-$68.79M
SWTX quarterly free cash flow is -$68.79 million

quarterly CFO

-$68.76M
SWTX quarterly cash flow from operations is -$68.76 million

quarterly CFI

$73.39M
SWTX quarterly cash flow from investing activities is $73.39 million

quarterly CFF

-$10.61M
SWTX quarterly cash flow from financing activities is -$10.61 million

TTM CAPEX:

$20.15M-$547.00K(-2.64%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX TTM capital expenditures is $20.15 million, with the most recent change of -$547.00 thousand (-2.64%) on March 31, 2025.
  • Over the past year, SWTX TTM CAPEX has increased by +$15.17 million (+304.29%).
  • SWTX TTM CAPEX is now -2.64% below its all-time high of $20.70 million, reached on December 31, 2024.

Performance

3-month change

-2.64%

1-year change

+304.29%

3-year change

+362.46%

5-year change

-

SWTX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

68.16%
SWTX TTM capital expenditures is higher than 68.16% of companies in Healthcare sector

Range

All-time high

$20.70M
SWTX TTM capital expenditures is currently -2.64% below its historical high of $20.70 million

3-year low

$4.99M
SWTX TTM capital expenditures is currently +304.29% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SWTX previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 7, 2025
SWTX next earnings announcement is scheduled for Aug 7, 2025

OtherSWTXcash flow metrics

TTM FCF

-$185.58M
SWTX TTM free cash flow is -$185.58 million

TTM CFO

-$165.43M
SWTX TTM cash flow from operations is -$165.43 million

TTM CFI

$116.47M
SWTX TTM cash flow from investing activities is $116.47 million

TTM CFF

-$5.29M
SWTX TTM cash flow from financing activities is -$5.29 million

SWTX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+180.3%-94.8%+304.3%
3 y3 years+926.8%-98.7%+362.5%
5 y5 years---

SWTX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+926.8%-99.8%+101.3%-2.6%+304.3%
5 y5-yearat high+3124.4%-99.8%+101.3%-2.6%>+9999.0%
alltimeall timeat high+3124.4%-99.8%+101.3%-2.6%>+9999.0%

SWTX CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$30.00K(-99.5%)
$20.15M(-2.6%)
Dec 2024
$20.70M(+180.3%)
$6.05M(+227.7%)
$20.70M(+67.7%)
Sep 2024
-
$1.85M(-84.9%)
$12.35M(-12.6%)
Jun 2024
-
$12.22M(+2018.7%)
$14.12M(+183.3%)
Mar 2024
-
$577.00K(-125.1%)
$4.99M(-32.5%)
Dec 2023
$7.38M(-27.6%)
-$2.30M(-163.6%)
$7.38M(-35.5%)
Sep 2023
-
$3.62M(+17.3%)
$11.44M(+0.8%)
Jun 2023
-
$3.09M(+3.7%)
$11.35M(+5.2%)
Mar 2023
-
$2.98M(+69.5%)
$10.79M(+5.8%)
DateAnnualQuarterlyTTM
Dec 2022
$10.20M(+405.8%)
$1.76M(-50.2%)
$10.20M(+2.5%)
Sep 2022
-
$3.53M(+39.7%)
$9.94M(+47.3%)
Jun 2022
-
$2.52M(+5.8%)
$6.75M(+54.9%)
Mar 2022
-
$2.39M(+58.7%)
$4.36M(+116.2%)
Dec 2021
$2.02M(+214.0%)
$1.50M(+349.0%)
$2.02M(+256.2%)
Sep 2021
-
$335.00K(+153.8%)
$566.00K(+145.0%)
Jun 2021
-
$132.00K(+193.3%)
$231.00K(+133.3%)
Mar 2021
-
$45.00K(-16.7%)
$99.00K(+83.3%)
Dec 2020
$642.00K
$54.00K
$54.00K

FAQ

  • What is SpringWorks Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual CAPEX year-on-year change?
  • What is SpringWorks Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly CAPEX year-on-year change?
  • What is SpringWorks Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics TTM CAPEX year-on-year change?

What is SpringWorks Therapeutics annual capital expenditures?

The current annual CAPEX of SWTX is $20.70M

What is the all time high annual CAPEX for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual capital expenditures is $20.70M

What is SpringWorks Therapeutics annual CAPEX year-on-year change?

Over the past year, SWTX annual capital expenditures has changed by +$13.32M (+180.31%)

What is SpringWorks Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of SWTX is $30.00K

What is the all time high quarterly CAPEX for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly capital expenditures is $12.22M

What is SpringWorks Therapeutics quarterly CAPEX year-on-year change?

Over the past year, SWTX quarterly capital expenditures has changed by -$547.00K (-94.80%)

What is SpringWorks Therapeutics TTM capital expenditures?

The current TTM CAPEX of SWTX is $20.15M

What is the all time high TTM CAPEX for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high TTM capital expenditures is $20.70M

What is SpringWorks Therapeutics TTM CAPEX year-on-year change?

Over the past year, SWTX TTM capital expenditures has changed by +$15.17M (+304.29%)
On this page